Kelly Lumpkins, M.D.

NPI 1922452218ActiveIndividual· Internal Medicine, Infectious Disease· Atlanta, GA

Internal Medicine, Infectious Disease (M.D.) in Atlanta, Georgia, trained at Medical College of Georgia School of Medicine (class of 2016). Their prescriptions cost Medicare Part D more than their services did: $427,543 for 326 claims, against $59,803 paid for services in 2024. Gilead Sciences, Inc. was the largest of 15 companies reporting payments in 2025, $1,510 in all, mostly food and beverage.

Overview

NPI	1922452218
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Apr 22, 2016
Last updated in NPPES	Feb 8, 2024
Certified by provider	Jul 19, 2021

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Infectious Disease Primary	207RI0200X	88115	GA
Student in an Organized Health Care Education/Training Program	390200000X	—	—

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Infectious Disease (GA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	212
Services billed	1,119 across 38 procedure codes
Paid by Medicare	$59,803

Part D prescriptions in 2024

Prescriptions (claims)	326 · 365 30-day fills
Patients	65
Total drug cost	$427,543
Generic share	71% of claims

Medicare sources and data years

Education and affiliations

Medical school	Medical College of Georgia School of Medicine
Graduation year	2016
Medicare specialty	Infectious Disease
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth